Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Bisphosphonate.
MEK1/2 inhibitor.
Endogenous peptide hormone inolved in gastric e...
Sulfonylurea; ATP-sensitive K+ channel blocker....
Staurosporine analog; PKC and PKA inhibitor.
HDAC inhibitor, RNA splicing modulator.
B-Raf and c-Raf inhibitor.
Peptide found in molluscs, cardiomodulator.
Excitatory amino acid found in seaweed; AMPA an...
p110δ PI3K inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Antimicrobial peptide found in amphibians.
V2 antagonist.
Ca2+ ATPase and ATP-sensitive K+ channel activa...
Laminin-derived hexapeptide.
Epoxide metabolite of acrylamide, induces DNA a...
Hydroxycinnamic aicd, verbascoside metabolite, ...
Reversible DNMT1-selective inhibitor
ALK5 (activin-like) antagonist.
Cephalotaxine alkaloid originally found in Ceph...